Relief Therap 
Welcome,         Profile    Billing    Logout  
 3 Products   36 Diseases   3 Products   4 Trials   668 News 


«123456»
  • ||||||||||  Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NRx Pharma
    Enrollment change:  AVINALI: Inhaled ZYESAMI (clinicaltrials.gov) -  Jun 8, 2021   
    P2/3,  N=144, Recruiting, 
    N=288 --> 144
  • ||||||||||  Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NRx Pharma
    Enrollment open, Phase classification, Trial initiation date:  Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS (clinicaltrials.gov) -  May 13, 2021   
    P2,  N=82, Recruiting, 
    N=288 --> 144 Not yet recruiting --> Recruiting | Phase classification: P1 --> P2 | Initiation date: Jan 2021 --> May 2021
  • ||||||||||  Zyesami IV (aviptadil intravenous) / Relief Therap, NRx Pharma
    Enrollment open:  TESICO: ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19 (clinicaltrials.gov) -  Apr 18, 2021   
    P3,  N=640, Recruiting, 
    Not yet recruiting --> Recruiting | Phase classification: P1 --> P2 | Initiation date: Jan 2021 --> May 2021 Not yet recruiting --> Recruiting
  • ||||||||||  Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
    $rlf $rlftf #aviptadil (Twitter) -  Mar 20, 2021   
  • ||||||||||  Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
    $RLFTF #RLF-100 Let’s go baby! (Twitter) -  Mar 16, 2021   
  • ||||||||||  Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx, Zyesami IV (aviptadil intravenous) / Relief Therap, NeuroRx
    [VIRTUAL] Rapid Recovery from COVID-19 Respiratory Failure with Comorbidity in 21 Patients Treated with Vasoactive Intestinal Peptide () -  Mar 14, 2021 - Abstract #ATS2021ATS_892;    
    The improvement in patients on ECOM was similar to that seen in patients treated with conventional mechanical ventilation. Available data from blood gases showed stark increases in PaO2:FiO2 ratio after the 2nd dose (Median increase = 92.5, IQR = 74) and at 24 hours after the 3rd dose (Median increase over baseline 84.5, IQR = 110).
  • ||||||||||  Zyesami IV (aviptadil intravenous) / Relief Therap, NRx Pharma
    Trial completion:  COVID-AIV: Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure (clinicaltrials.gov) -  Feb 25, 2021   
    P2/3,  N=196, Completed, 
    Available data from blood gases showed stark increases in PaO2:FiO2 ratio after the 2nd dose (Median increase = 92.5, IQR = 74) and at 24 hours after the 3rd dose (Median increase over baseline 84.5, IQR = 110). Active, not recruiting --> Completed
  • ||||||||||  Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NRx Pharma
    Enrollment open:  AVINALI: Inhaled ZYESAMI (clinicaltrials.gov) -  Feb 21, 2021   
    P2/3,  N=288, Recruiting, 
    Active, not recruiting --> Completed Not yet recruiting --> Recruiting
  • ||||||||||  aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
    What about RLF-100? (Twitter) -  Jan 14, 2021   
  • ||||||||||  Zyesami IV (aviptadil intravenous) / Relief Therap, NRx Pharma
    Enrollment closed, Phase classification:  COVID-AIV: Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure (clinicaltrials.gov) -  Dec 28, 2020   
    P2/3,  N=196, Active, not recruiting, 
    Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting | Phase classification: P2 --> P2/3
  • ||||||||||  aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
    One exists....aviptadil (Twitter) -  Dec 23, 2020   
  • ||||||||||  aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
    #AviptadilStopsCovid #RLF100 (Twitter) -  Dec 6, 2020